A new study has shed light on a previously unknown pathway that may contribute to the deadliness of pancreatic cancer. Research has also led to the development of potential new treatments, including a drug that may nearly double survival rates in some patients and a vaccine that has shown promising results in early trials. The effectiveness and potential applications of these treatments are still being explored, with some studies suggesting they could have a significant impact on survival rates for pancreatic cancer patients.